Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 720672 ST. LOUIS, MO
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,903,617
-$225,643 QoQ
Shares Held
62,430
+3.1% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $141,737,028 across 29 Drug Manufacturers - Specialty & Generic names. SUPN ranks #13 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HLN
Haleon plc
 2,604,559 $24,300,533
2 BCRX
Biocryst Pharmaceuticals Inc
 1,826,234 $18,262,340
3 ZTS
Zoetis Inc.
 252,429 $18,139,545
4 VTRS
Viatris Inc
 924,858 $14,686,743
5 TAK
Takeda Pharmaceutical Co Ltd
 722,863 $11,587,493
6 ELAN
Elanco Animal Health Inc
 317,401 $7,811,236
7 HROW
Harrow, Inc.
 180,893 $7,682,525
8 TEVA
Teva Pharmaceutical Industries Ltd
 198,546 $6,726,737

All Filings in SUPN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,903,617 62,430
2026-03-31 $3,129,260 60,539
2025-12-31 $2,503,885 50,380
2025-09-30 $2,999,060 62,755
2025-06-30 $2,004,482 63,594
2025-03-31 $2,347,650 71,684
2024-12-31 $2,457,541 67,963
2024-09-30 $2,155,597 69,134
2024-06-30 $1,820,096 68,041
2024-03-31 $2,364,333 69,315
2023-12-31 $1,575,868 54,453
2023-09-30 $1,408,274 51,080
2023-06-30 $1,238,171 41,190
2023-03-31 $1,319,713 36,426
2022-12-31 $1,295,712 36,325
2022-09-30 $1,162,611 34,346
2022-06-30 $902,650 31,212
2022-03-31 $885,018 27,383
2021-12-31 $754,631 25,879
2021-09-30 $615,676 23,085
2021-06-30 $534,236 17,351
2021-03-31 $381,966 14,590
2020-12-31 $319,708 12,707
2020-09-30 $237,805 11,411
2020-06-30 $260,347 10,962
2020-03-31 $228,346 12,693